CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
radiofrequencydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06678061
NCT06678061N/ACompleted

Efficacy of Radiofrequency Splanchnic Denervation Compared to Neurolytic Retrocrural Celiac Plexus Block for Patients With Chronic Upper Abdominal Cancer Pain

Assiut University·interventional·Posted Nov 7, 2024·Updated Nov 7, 2024

In Brief

A clinical study evaluating radiofrequency for Cancer. Completed, enrolled 50 participants across 2 sites.

Detailed Summary

To compare between the efficacy of radiofrequency splanchnic denervation and neurolytic retrocrural celiac plexus block in chronic upper abdominal cancer pain

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedNov 7, 2024
Enrollment StartFeb 1, 2024
Primary CompletionJul 1, 2024
Study CompletionAug 1, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 1.7 years ago

Interventions

radiofrequencydevice

block of neurolytic retrocrural celiac plexus block